A randomised controlled trial of a fluid containing 140mmol/L of sodium compared to a fluid containing 77mmol/L of sodium for maintenance intravenous fluid therapy in hospitalised children.

一项随机对照试验，对住院儿童进行维持静脉输液治疗时使用含 140 mmol/L 钠的液体与含 77 mmol/L 钠的液体进行比较。

• 批准号: nhmrc : 1025962
• 负责人: A/Pr Franz Babl
• 金额: $ 12.27万
• 依托单位: Murdoch Childrens Research Institute
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/randomised-controlled-trial-hospitalised-children/110460
• 关键词: randomised; controlled; trial; fluid; containing

Intravenous fluid therapy is one of the most common and important treatments for children in hospital. In spite of this we know very little about what fluid should be used and there is now good evidence that children are experiencing adverse outcomes because of fluid treatment. The aim of this trial is to determine which intravenous fluid is best in children. It will be the largest and most relevant intravenous fluid trial performed in children. The results will have an immediate impact on treating children worldwide.

静脉输液是小儿最常见、最重要的治疗手段之一。尽管如此，我们对应该使用什么液体知之甚少，现在有充分的证据表明，由于液体治疗，儿童正在经历不良后果。本试验的目的是确定哪种静脉输液对儿童最好。这将是在儿童中进行的最大和最相关的静脉输液试验。研究结果将对全世界儿童的治疗产生直接影响。